Natural Course of Neuroblastoma Detected by Mass Screening: A 5-Year Prospective Study at a Single Institution
- 16 August 2000
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 18 (16) , 3012-3017
- https://doi.org/10.1200/jco.2000.18.16.3012
Abstract
PURPOSE: To describe various favorable courses of neuroblastoma (NBL) detected by mass screening and to present our observation program as a temporary treatment option, to be used until a final decision is made regarding the mass screening program for 6-month-old infants. PATIENTS AND METHODS: Between October 1993 and November 1999, 26 of 51 patients with NBL detected by mass screening were enrolled in our observation program. The criteria for observation included urinary vanillylmandelic acid (VMA) and homovanillic acid (HVA) levels less than 50 μg/mg creatinine, smaller tumor size (< 5.0 cm), preoperative status, and granted informed consent. Patients were divided into four groups according to changes in urinary VMA and HVA values and tumor size. Patients who no longer fulfilled criteria underwent surgery. RESULTS: The observation period ranged from 4 to 73 months. Urinary VMA and HVA levels decreased in 19 of 26 patients, often by age 16 months. Eighteen patients had regressing tumors, and in 10 of these cases, the tumor was undetectable or barely detectable by imaging techniques. Four patients younger than 12 months had increased tumor marker levels and tumor volume, histologically reflecting neuroblastic proliferation. The remaining three patients, all older than 18 months, had varied tumor marker levels but increased tumor volume, histologically reflecting an increase in Schwann cells. No upgrading of tumor stage or unfavorable biologic factor was noted in any patient. CONCLUSION: None of our patients showed evidence of transition from favorable to unfavorable prognosis, a finding that points to a reduction in the significance of screening as a public health measure. Until results of ongoing screening trials involving older patients have been evaluated, the observation program can be used as a temporary measure to avoid, with little risk, unnecessary surgical intervention.Keywords
This publication has 22 references indexed in Scilit:
- Report of the 1998 consensus conference on neuroblastoma screeningMedical and Pediatric Oncology, 1999
- Early detection of neuroblastoma in infants: Research? Yes. Routine screening? No.Medical and Pediatric Oncology, 1999
- Spontaneous regression of localized neuroblastoma detected by mass screening.Journal of Clinical Oncology, 1998
- A population-based study of the usefulness of screening for neuroblastomaThe Lancet, 1996
- Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy.Journal of Clinical Oncology, 1996
- Mass screening in Japan increased the detection of infants with neuroblastoma without a decrease in cases in older childrenThe Journal of Pediatrics, 1991
- Spontaneous regression of neuroblastoma detected by mass screeningThe Lancet, 1991
- Complete pathologic maturation and regression of stage ivs neuroblastoma without treatmentCancer, 1988
- Prognostic significance of tumor volume in localized Ewing's sarcoma of bone in children and adolescentsZeitschrift für Krebsforschung und Klinische Onkologie, 1987
- MASS SCREENING FOR NEUROBLASTOMA IN INFANTS IN JAPANThe Lancet, 1984